MedPath
HSA Approval

SODIUM BICARBONATE INTRAVENOUS INFUSION BP 4.2% w/v

SIN09851P

SODIUM BICARBONATE INTRAVENOUS INFUSION BP 4.2% w/v

SODIUM BICARBONATE INTRAVENOUS INFUSION BP 4.2% w/v

June 26, 1998

B. BRAUN SINGAPORE PTE LTD

B. BRAUN SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantB. BRAUN SINGAPORE PTE LTD
Licence HolderB. BRAUN SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

B05XA02

sodium bicarbonate

Manufacturer Information

B. Braun Singapore Pte Ltd.

B BRAUN MELSUNGEN AG

Active Ingredients

SODIUM BICARBONATE

4.2% w/v

Sodium bicarbonate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SODIUM BICARBONATE INTRAVENOUS INFUSION BP 4.2% w/v - HSA Approval | MedPath